Literature DB >> 30276538

De novo unbalanced translocations have a complex history/aetiology.

Maria Clara Bonaglia1, Nehir Edibe Kurtas2, Edoardo Errichiello2, Sara Bertuzzo3, Silvana Beri3, Mana M Mehrjouy4, Aldesia Provenzano5, Debora Vergani2, Vanna Pecile6, Francesca Novara2, Paolo Reho5, Marilena Carmela Di Giacomo7, Giancarlo Discepoli8, Roberto Giorda9, Micheala A Aldred10, Cíntia Barros Santos-Rebouças11, Andressa Pereira Goncalves11, Diane N Abuelo12, Sabrina Giglio5, Ivana Ricca13, Fabrizia Franchi14, Philippos Patsalis15, Carolina Sismani15, María Angeles Morí16, Julián Nevado16, Niels Tommerup4, Orsetta Zuffardi17.   

Abstract

We investigated 52 cases of de novo unbalanced translocations, consisting in a terminally deleted or inverted-duplicated deleted (inv-dup del) 46th chromosome to which the distal portion of another chromosome or its opposite end was transposed. Array CGH, whole-genome sequencing, qPCR, FISH, and trio genotyping were applied. A biparental origin of the deletion and duplication was detected in 6 cases, whereas in 46, both imbalances have the same parental origin. Moreover, the duplicated region was of maternal origin in more than half of the cases, with 25% of them showing two maternal and one paternal haplotype. In all these cases, maternal age was increased. These findings indicate that the primary driver for the occurrence of the de novo unbalanced translocations is a maternal meiotic non-disjunction, followed by partial trisomy rescue of the supernumerary chromosome present in the trisomic zygote. In contrast, asymmetric breakage of a dicentric chromosome, originated either at the meiosis or postzygotically, in which the two resulting chromosomes, one being deleted and the other one inv-dup del, are repaired by telomere capture, appears at the basis of all inv-dup del translocations. Notably, this mechanism also fits with the origin of some simple translocations in which the duplicated region was of paternal origin. In all cases, the signature at the translocation junctions was that of non-homologous end joining (NHEJ) rather than non-allelic homologous recombination (NAHR). Our data imply that there is no risk of recurrence in the following pregnancies for any of the de novo unbalanced translocations we discuss here.

Entities:  

Keywords:  Chromothripsis; Meiosis; Mosaicism; Parental origin; Telomere capture; Trisomy rescue

Mesh:

Year:  2018        PMID: 30276538     DOI: 10.1007/s00439-018-1941-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  51 in total

1.  Unusual 8p inverted duplication deletion with telomere capture from 8q.

Authors:  Karen Buysse; Francesca Antonacci; Bert Callewaert; Bart Loeys; Ulrike Fränkel; Victoria Siu; Geert Mortier; Frank Speleman; Björn Menten
Journal:  Eur J Med Genet       Date:  2008-11-17       Impact factor: 2.708

2.  Molecular investigation of the parental origin of a de novo unbalanced translocation 13/18.

Authors:  T Eggermann; H Engels; C Heidrich-Kaul; I Moderau; G Schwanitz
Journal:  Hum Genet       Date:  1997-04       Impact factor: 4.132

Review 3.  The Genomic Characteristics and Origin of Chromothripsis.

Authors:  Alessio Marcozzi; Franck Pellestor; Wigard P Kloosterman
Journal:  Methods Mol Biol       Date:  2018

Review 4.  The 3D Genome as Moderator of Chromosomal Communication.

Authors:  Job Dekker; Leonid Mirny
Journal:  Cell       Date:  2016-03-10       Impact factor: 41.582

5.  Selective Y centromere inactivation triggers chromosome shattering in micronuclei and repair by non-homologous end joining.

Authors:  Peter Ly; Levi S Teitz; Dong H Kim; Ofer Shoshani; Helen Skaletsky; Daniele Fachinetti; David C Page; Don W Cleveland
Journal:  Nat Cell Biol       Date:  2016-12-05       Impact factor: 28.824

Review 6.  Somatic mosaicism: implications for disease and transmission genetics.

Authors:  Ian M Campbell; Chad A Shaw; Pawel Stankiewicz; James R Lupski
Journal:  Trends Genet       Date:  2015-04-21       Impact factor: 11.639

7.  Somatic mosaicism detected by exon-targeted, high-resolution aCGH in 10,362 consecutive cases.

Authors:  Justin Pham; Chad Shaw; Amber Pursley; Patricia Hixson; Srirangan Sampath; Erin Roney; Tomasz Gambin; Sung-Hae L Kang; Weimin Bi; Seema Lalani; Carlos Bacino; James R Lupski; Pawel Stankiewicz; Ankita Patel; Sau-Wai Cheung
Journal:  Eur J Hum Genet       Date:  2014-01-08       Impact factor: 4.246

8.  Mechanisms for Complex Chromosomal Insertions.

Authors:  Shen Gu; Przemyslaw Szafranski; Zeynep Coban Akdemir; Bo Yuan; Mitchell L Cooper; Maria A Magriñá; Carlos A Bacino; Seema R Lalani; Amy M Breman; Janice L Smith; Ankita Patel; Rodger H Song; Weimin Bi; Sau Wai Cheung; Claudia M B Carvalho; Paweł Stankiewicz; James R Lupski
Journal:  PLoS Genet       Date:  2016-11-23       Impact factor: 5.917

9.  ChimerDB 2.0--a knowledgebase for fusion genes updated.

Authors:  Pora Kim; Suhyeon Yoon; Namshin Kim; Sanghyun Lee; Minjeong Ko; Haeseung Lee; Hyunjung Kang; Jaesang Kim; Sanghyuk Lee
Journal:  Nucleic Acids Res       Date:  2009-11-11       Impact factor: 16.971

10.  Analysis of the features and source gene composition of the AluYg6 subfamily of human retrotransposons.

Authors:  Pamela Styles; John F Y Brookfield
Journal:  BMC Evol Biol       Date:  2007-07-01       Impact factor: 3.260

View more
  3 in total

1.  Application of full-genome analysis to diagnose rare monogenic disorders.

Authors:  Joseph T Shieh; Monica Penon-Portmann; Karen H Y Wong; Michal Levy-Sakin; Michelle Verghese; Anne Slavotinek; Renata C Gallagher; Bryce A Mendelsohn; Jessica Tenney; Daniah Beleford; Hazel Perry; Stephen K Chow; Andrew G Sharo; Steven E Brenner; Zhongxia Qi; Jingwei Yu; Ophir D Klein; David Martin; Pui-Yan Kwok; Dario Boffelli
Journal:  NPJ Genom Med       Date:  2021-09-23       Impact factor: 6.083

2.  De novo 8p21.3→ p23.3 Duplication With t(4;8)(q35;p21.3) Translocation Associated With Mental Retardation, Autism Spectrum Disorder, and Congenital Heart Defects: Case Report With Literature Review.

Authors:  Cristina Gug; Dorina Stoicanescu; Ioana Mozos; Laura Nussbaum; Mariana Cevei; Danae Stambouli; Anca Gabriela Pavel; Gabriela Doros
Journal:  Front Pediatr       Date:  2020-07-08       Impact factor: 3.418

3.  Targeted next-generation sequencing identifies the disruption of the SHANK3 and RYR2 genes in a patient carrying a de novo t(1;22)(q43;q13.3) associated with signs of Phelan-McDermid syndrome.

Authors:  Maria Clara Bonaglia; Sara Bertuzzo; Anna Maria Ciaschini; Giancarlo Discepoli; Lucia Castiglia; Romina Romaniello; Orsetta Zuffardi; Marco Fichera
Journal:  Mol Cytogenet       Date:  2020-06-11       Impact factor: 2.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.